| è´§å· | å“牌 | 产å“åç§° | è§„æ ¼ | 包装ã€å‚è€ƒä»·æ ¼ | |
| T2286 | TCI | Trimethoprim | >98.0%(T)(HPLC) | 420元/25G; 990元/100G; 2990元/500G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 纯度/åˆ†æžæ–¹æ³• | >98.0%(T)(HPLC) | | 分åå¼/分åé‡ | C14H18N4O3 = 290.32 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 625127 | | PubChem物质ID | 87558288 | | Merck Index (14) | 9709 |
æŠ€æœ¯è§„æ ¼ | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Melting point | 199.0 to 205.0 ℃ | | Solubility in hot Methanol | almost transparency |
物性(å‚考值) | 熔点 | 202 ℃ | | 水溶性 | 䏿º¶ | | 在水ä¸çš„æº¶è§£åº¦ | 400 mg/l 25 ℃ | | 溶解性(微溶于) | 氯仿,甲醇 | | 溶解性(䏿º¶äºŽ) | 苯,乙醚 |
相关法规 |
| 453948 | J&K | Trimethoprim | 98% | 154元/5G; 613元/25G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 分åå¼ | C14H18N4O3 | | 分åé‡ | 290.32 | | 熔点 | 199-205 | | MDLç¼–ç | MFCD00036761 | | Beilstein | 625127 | | Merck | 14,9709 | | EINECS ç¼–å· | 212-006-2 | | å˜å‚¨æ¡ä»¶ | Store at 2-8℃ | 一般æè¿° 化å¦ç»“构:嘧啶 应用 甲氧苄啶是最主è¦çš„æŠ—细èŒå‰‚。 它有二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ å®ƒè¢«ç”¨æ¥æ²»ç–—å°¿é“æ„ŸæŸ“,轻度急性å‰åˆ—腺炎,å¤å‘æ€§è†€èƒ±ç‚Žï¼Œæ€€å•æœŸé—´æ— 症状èŒå°¿å’Œå‘¼å¸é“感染。主è¦ä½œä¸ºæŠ—细èŒå‰‚。 二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ 生化/生ç†ä½œç”¨ 甲氧苄啶和磺胺甲æ¶å”‘结åˆï¼Œé€šè¿‡é˜»ç¢æ ¸è‹·é…¸åˆæˆï¼Œå¹²æ‰°ç»†èŒç»†èƒžå¶é…¸ç»†èƒžä»£è°¢ã€‚ 甲氧苄啶和二氢å¶é…¸è¿˜åŽŸé…¶ç»“åˆï¼ŒæŠ‘制二氢å¶é…¸ï¼ˆDHF)和四氢å¶é…¸ï¼ˆTHF)还原。THFæ˜¯èƒ¸è…ºå˜§å•¶åˆæˆé€”径基本å‰ä½“,干扰该途径,抑制细èŒDNAåˆæˆã€‚ 其他说明 ä¿æŒå®¹å™¨å¯†é—,置于干燥通风处。置于干燥处。 å®‰å…¨ä¿¡æ¯ | 防范说明 | P262 | | WGK | 3 | | RTECS | UV8225000 |
|
| J63053 | Alfa Aesar | Trimethoprim | | 333元/1g; 1334元/5g; 3320元/25g; | 咨询 |
应用 An antibacterial and inhibitor of formylation. Dihydrofolate reductase inhibitor with selectivity for the prokaryote enzyme.Trimethoprim is an antibiotic involved in the treatment of urinary tract infections, middle ear infections and traveler?’s diarrhea. It is associated with sulfamethoxazole and interferes with the cellular metabolism of folic acid in the bacterial cell by blocking the biosynthesis of nucleotides. Furthermore, It is also used to treat and prevent Pneumocystis jiroveci pneumonia. 备注 Sensitive to light. Incompatible with strong oxidizing agents. Sore in a cool place. åŸºæœ¬ä¿¡æ¯ MDL MFCD00036761 EINECS 212-006-2 分åå¼ C14H18N4O3 分åé‡ 290.32 熔点 199-203° çµæ•度 Keep Cold. å½¢æ€ Powder 溶解性 Trimethoprim is soluble in water at 0.4 mg/ml. It is also soluble in DMSO at 50 mg/ml and chloroform at 18.2 mg/ml. Soluble in methanol, chloroform, dimethyl sulfoxide, N,N-dimethylacetamide, benzyl alcohol, and propylene glycol. Insoluble in water, diethyl ether and benzene. Beilstein 625127 Merck 14,9709 å®‰å…¨ä¿¡æ¯ RTECS UV8225000 TSCA å¦ |
| R10838 | Alfa Aesar | Trimethoprim Standard solution | 100ppm | 335元/1ml; | 咨询 |
|
| R11925 | Alfa Aesar | Trimethoprim,1000ppm | | 704元/1ml; | 咨询 |
|
| Y0000684 | | Trimethoprim for system suitability | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 应用 主è¦ä½œä¸ºæŠ—细èŒå‰‚。 二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ 包装 Unit quantity: 0.001 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. æ³¨æ„ Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H18N4O3 | | 分åé‡ | 290.32 | | Beilstein | 625127 | | MDLç¼–å· | MFCD00036761 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329831095 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | å±é™©åˆ†ç±» | Acute Tox. 3 Oral - Repr. 2 | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| T7883 | Sigma-Aldrich | Trimethoprim | ≥98.5% | 1742.3å…ƒ/5 g; 6684.71å…ƒ/25 g; 14390.2å…ƒ/100 g; | 咨询 |
产å“说明 一般æè¿° 化å¦ç»“构:嘧啶 应用 甲氧苄啶是最主è¦çš„æŠ—细èŒå‰‚。 它有二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ å®ƒè¢«ç”¨æ¥æ²»ç–—å°¿é“æ„ŸæŸ“,轻度急性å‰åˆ—腺炎,å¤å‘æ€§è†€èƒ±ç‚Žï¼Œæ€€å•æœŸé—´æ— 症状èŒå°¿å’Œå‘¼å¸é“感染。 主è¦ä½œä¸ºæŠ—细èŒå‰‚。 二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ 生化/生ç†ä½œç”¨ 甲氧苄啶和磺胺甲æ¶å”‘结åˆï¼Œé€šè¿‡é˜»ç¢æ ¸è‹·é…¸åˆæˆï¼Œå¹²æ‰°ç»†èŒç»†èƒžå¶é…¸ç»†èƒžä»£è°¢ã€‚ 甲氧苄啶和二氢å¶é…¸è¿˜åŽŸé…¶ç»“åˆï¼ŒæŠ‘制二氢å¶é…¸(DHF)和四氢å¶é…¸(THF)还原。THFæ˜¯èƒ¸è…ºå˜§å•¶åˆæˆé€”径基本å‰ä½“,干扰该途径,抑制细èŒDNAåˆæˆã€‚ 包装 5G,25G,100G 其他说明 ä¿æŒå®¹å™¨å¯†é—,置于干燥通风处。置于干燥处。 åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H18N4O3 | | 分åé‡ | 290.32 | | Beilstein | 625127 | | EC å· | 212-006-2 | | MDLç¼–å· | MFCD00036761 | | PubChem化å¦ç‰©è´¨ç¼–å· | 24278201 | | NACRES | NA.85 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 200 | | 测定 | ≥98% (HPLC) | | å½¢å¼ | powder | | å‚¨å˜æ¡ä»¶ | (Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place.) | | 颜色 | white to off-white | | 溶解性 | chloroform/ethanol (1:1): soluble 50 mg/mL DMSO: soluble | | 作用机制 | DNA synthesis | interferes enzyme | inhibits | | æŠ—ç”Ÿç´ æŠ—èŒè°± | Gram-negative bacteria Gram-positive bacteria mycobacteria | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N | | Gene Information | human ... DHFRP1(573971), KCNH1(3756) rat ... Dhfr(24312) |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | å±é™©åˆ†ç±» | Acute Tox. 3 Oral - Repr. 2 | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type N95 (US) |
|
| 92131 | Sigma-Aldrich | Trimethoprim | ≥99.0% (HPLC) | 603.83å…ƒ/1 g; 1782.29å…ƒ/5 g; 6997.08å…ƒ/25 g; | 咨询 |
产å“说明 一般æè¿° 化å¦ç»“构:嘧啶 应用 甲氧苄啶主è¦ç”¨ä½œæŠ—èŒå‰‚ã€‚ç”¨äºŽç»“æ ¸åˆ†æžæ†èŒçš„æ•æ„Ÿæ€§ç ”ç©¶å’Œæµæ„Ÿå—œè¡€æ†èŒçš„è€è¯æ€§ç ”究。 主è¦ä½œä¸ºæŠ—细èŒå‰‚。 二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ 生化/生ç†ä½œç”¨ 甲氧苄啶是一ç§äºŒæ°¢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶å‰‚ï¼Œå¯¹åŽŸæ ¸ç”Ÿç‰©é…¶å…·æœ‰é€‰æ‹©æ€§ã€‚ é€šè¿‡åŽŸæ ¸ç”Ÿç‰©ç‰¹å¼‚çš„äºŒæ°¢å¶é…¸è¿˜åŽŸé…¶(DHFR)抑制四氢å¶é…¸çš„åˆæˆã€‚ 包装 1gã€5gã€25g 其他说明 将容器密é—ä¿å˜åœ¨å¹²ç‡¥é€šé£Žçš„åœ°æ–¹ã€‚å¯¹å…‰æ•æ„Ÿã€‚在惰性气体下储å˜ã€‚å¯¹æ°´åˆ†æ•æ„Ÿã€‚产å“å¯¹å…‰å’Œæ°´åˆ†æ•æ„Ÿã€‚ åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H18N4O3 | | 分åé‡ | 290.32 | | Beilstein | 625127 | | EC å· | 212-006-2 | | MDLç¼–å· | MFCD00036761 | | PubChem化å¦ç‰©è´¨ç¼–å· | 57653467 | | NACRES | NA.85 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 200 | | ç”Ÿç‰©æ¥æº | synthetic | | 测定 | ≥99.0% (HPLC) | | å½¢å¼ | powder | | è´¨é‡ | crystallized | | 颜色 | white to yellow | | mp | 199-203 ℃ | | 作用机制 | DNA synthesis | interferes enzyme | inhibits | | æŠ—ç”Ÿç´ æŠ—èŒè°± | Gram-negative bacteria Gram-positive bacteria mycobacteria | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N | | Gene Information | human ... DHFRP1(573971), KCNH1(3756) rat ... Dhfr(24312) |
å®‰å…¨ä¿¡æ¯ | 象形图 |  | | è¦ç¤ºç”¨è¯ï¼š | Warning | | å±é™©å£°æ˜Ž | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral | | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type N95 (US) |
|
| 46984 | Supelco | Trimethoprim | VETRANAL®, analytical standard | 761.09å…ƒ/250 MG; | 咨询 |
产å“说明 一般æè¿° 化å¦ç»“构:嘧啶 应用 有关åˆé€‚仪器技术的更多信æ¯ï¼Œè¯·å‚考产å“分æžè¯ä¹¦ã€‚å¦‚éœ€è¿›ä¸€æ¥æ”¯æŒï¼Œè¯·è”系技术æœåŠ¡ã€‚ 主è¦ä½œä¸ºæŠ—细èŒå‰‚。 二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ æ³•å¾‹ä¿¡æ¯ VETRANAL is a registered trademark of sigma-aldrich Chemie GmbH åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H18N4O3 | | 分åé‡ | 290.32 | | Beilstein | 625127 | | EC å· | 212-006-2 | | MDLç¼–å· | MFCD00036761 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329757283 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 100 | | ç‰çº§ | analytical standard | | agency | EPA 1694 | | 产å“线 | VETRANAL® | | ä¿è´¨æœŸ | limited shelf life, expiry date on the label | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | æŠ—ç”Ÿç´ æŠ—èŒè°± | Gram-negative bacteria Gram-positive bacteria mycoplasma | | application(s) | clinical testing | | æ ¼å¼ | neat | | 作用机制 | DNA synthesis | interferes enzyme | inhibits | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | å±é™©åˆ†ç±» | Acute Tox. 3 Oral - Repr. 2 | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type N95 (US) |
|
| PHR1056 | Supelco | Trimethoprim | Pharmaceutical Secondary Standard; Certified Reference Material | 1359.83元/1 G; | 咨询 |
产å“说明 一般æè¿° ç”¨äºŽè´¨é‡æŽ§åˆ¶çš„å·²è®¤è¯çš„è¯ç‰©äºŒçº§æ ‡å‡†ï¼Œä¸ºåˆ¶è¯å®žéªŒå®¤å’Œåˆ¶é€ 商æä¾›äº†è¯å…¸åŸºæœ¬æ ‡å‡†çš„ä¸€ç§æ–¹ä¾¿ä¸”æˆæœ¬æ•ˆç›Šå¥½çš„æ›¿ä»£å“。甲氧苄啶是一ç§åˆæˆçš„æŠ—èŒå‰‚,对大多数需氧é©å…°æ°é˜´æ€§å’Œé©å…°æ°é˜³æ€§ç»†èŒå…·æœ‰ä½“å¤–æŠ—èŒæ´»æ€§ã€‚å®ƒçš„ä½œç”¨æ–¹å¼æ¶‰åŠåˆ°æŠ‘制二氢å¶é…¸è¿˜åŽŸé…¶ï¼Œè¿™æ˜¯ä¸€ç§å¯åœ¨å¾®ç”Ÿç‰©å’ŒçœŸæ ¸ç»†èƒžä¸å‚¬åŒ–将二氢å¶é…¸è¿˜åŽŸä¸ºå››æ°¢å¶é…¸çš„酶。 应用 甲氧苄啶å¯ä½œä¸ºè¯ç‰©å‚è€ƒæ ‡å‡†å“,通过色谱以åŠå¯è§å…‰å’Œç´«å¤–分光光度技术对è¯ç‰©åˆ¶å‰‚ä¸çš„分æžç‰©è¿›è¡Œæµ‹å®šã€‚ è¿™äº›äºŒçº§æ ‡å‡†å“æ˜¯åˆæ ¼çš„è®¤è¯æ ‡å‡†ç‰©è´¨(CRM)。它们适用于多ç§åˆ†æžåº”用,包括但ä¸é™äºŽè¯ç‰©é‡Šæ”¾æµ‹è¯•ã€è¯ç‰©çš„定性和定é‡åˆ†æžæ–¹æ³•å¼€å‘ã€é£Ÿå“å’Œé¥®æ–™è´¨é‡æŽ§åˆ¶æ£€æµ‹ä»¥åŠå…¶ä»–æ ¡å‡†éœ€æ±‚ã€‚ 主è¦ä½œä¸ºæŠ—细èŒå‰‚。 二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ 分æžè¯´æ˜Ž è¿™äº›äºŒçº§æ ‡å‡†å“å¯è¿½æº¯è‡³USPã€EP(PhEur)å’ŒBPä¸€çº§æ ‡å‡†å“。 其他说明 该认è¯å‚考物质 (CRM) 按照 ISO 17034 å’Œ ISO/IEC 17025 生产和认è¯ã€‚æ‰€æœ‰å…³äºŽæ¤ CRM 的信æ¯å‡è®°è½½åœ¨åˆ†æžè¯ä¹¦ä¸ã€‚ 附注 è¦æŸ¥çœ‹è¯¥ææ–™çš„分æžè¯ä¹¦ç¤ºä¾‹ï¼Œè¯·åœ¨ä¸‹é¢çš„æ ä½ä¸è¾“å…¥ LRAA7172ã€‚è¿™åªæ˜¯ä¸€ä¸ªç¤ºä¾‹è¯ä¹¦ï¼Œå¯èƒ½ä¸æ˜¯æ‚¨æ”¶åˆ°çš„æ‰¹æ¬¡ã€‚ åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H18N4O3 | | 分åé‡ | 290.32 | | Beilstein | 625127 | | EC å· | 212-006-2 | | MDLç¼–å· | MFCD00036761 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329823086 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 300 | | ç‰çº§ | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | è¯å…¸å¯è¿½æº¯æ€§ | traceable to BP 344 traceable to PhEur T220000 traceable to USP 1692505 | | å‚¨å˜æ¸©åº¦ | 2-30℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | å±é™©åˆ†ç±» | Acute Tox. 3 Oral - Repr. 2 | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| T2200000 | | Trimethoprim | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 应用 主è¦ä½œä¸ºæŠ—细èŒå‰‚。 二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. æ³¨æ„ Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H18N4O3 | | 分åé‡ | 290.32 | | Beilstein | 625127 | | MDLç¼–å· | MFCD00036761 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329826703 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | å±é™©åˆ†ç±» | Acute Tox. 3 Oral - Repr. 2 | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 16967 | Supelco | Trimethoprim | certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland | 1755.66å…ƒ/100 mg; | 咨询 |
产å“说明 一般æè¿° è¯¥æœ‰è¯æ ‡å‡†ç‰©è´¨(CRM)æ˜¯æ ¹æ®ISO/IEC 17025å’ŒISO 17034生产和认è¯çš„。该CRMå¯è¿½æº¯åˆ°æ¥è‡ªNMIçš„åŽŸææ–™ï¼Œå¦‚ NIST或NMIJ。 è¯ä¹¦ä¸Šç»™å‡ºäº†å®šé‡æ ¸ç£å…±æŒ¯æ³•认è¯çš„内容,包括ä¸ç¡®å®šæ€§å’Œå¤±æ•ˆæ—¥æœŸã€‚ 请访问http://www.sigma-aldrich.com下载您的è¯ä¹¦ã€‚ 应用 主è¦ä½œä¸ºæŠ—细èŒå‰‚。 二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ æ³•å¾‹ä¿¡æ¯ TraceCERT is a registered trademark of sigma-aldrich Co. LLC åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H18N4O3 | | 分åé‡ | 290.32 | | Beilstein | 625127 | | EC å· | 212-006-2 | | MDLç¼–å· | MFCD00036761 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 300 | | ç‰çº§ | certified reference material TraceCERT® | | 产å“线 | TraceCERT® | | ä¿è´¨æœŸ | limited shelf life, expiry date on the label | | technique(s) | gas chromatography (GC): suitable | | application(s) | forensics and toxicology pharmaceutical (small molecule) | | æ ¼å¼ | neat | | è¿è¾“ | wet ice | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | å±é™©åˆ†ç±» | Acute Tox. 3 Oral - Repr. 2 | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP344 | | Trimethoprim | British Pharmacopoeia (BP) Reference Standard | 1952.55元/100 MG; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 应用 主è¦ä½œä¸ºæŠ—细èŒå‰‚。 二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H18N4O3 | | 分åé‡ | 290.32 | | Beilstein | 625127 | | EC å· | 212-006-2 | | MDLç¼–å· | MFCD00036761 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | BP | | æ ¼å¼ | neat | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | å±é™©åˆ†ç±» | Acute Tox. 3 Oral - Repr. 2 | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1692505 | USP | Trimethoprim | United States Pharmacopeia (USP) Reference Standard | 3231.47元/300 MG; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 应用 主è¦ä½œä¸ºæŠ—细èŒå‰‚。 二氢å¶é…¸è¿˜åŽŸé…¶æŠ‘åˆ¶æ´»æ€§å’ŒåŽŸæ ¸é…¶é€‰æ‹©æ€§ã€‚ 分æžè¯´æ˜Ž These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H18N4O3 | | 分åé‡ | 290.32 | | Beilstein | 625127 | | MDLç¼–å· | MFCD00036761 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329751414 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | SMILES string | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC | | InChI | 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) | | InChI key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H301 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P310 - P405 | | å±é™©åˆ†ç±» | Acute Tox. 3 Oral - Repr. 2 | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|